Back to Authors

Oliveira, Carolina Leite De

A5065216789 | I186523950

Mayo Clinic

Regeneron (United States)

Citations 3

P1083: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA GRADE 1–3A: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE 2 STUDY ELM-2

HemaSphere | August 8, 2023 | Volume: 7 | Issue: S3 | Pages: e214536e

10.1097/01.hs9.0000971228.21453.6e

ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) GRADE 1–3A: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE II STUDY ELM‐2

Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 121-122

10.1002/hon.3163_82

Odronextamab in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Grade 1-3a: Results from a Prespecified Analysis of the Pivotal Phase II Study ELM-2

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2280-2282

10.1182/blood-2022-158404